Understanding differences in survival across distinct subgroups of melanoma patients may help with the choice of types of therapy. Tumor-infiltrating lymphocytes (TILs) are considered a manifestation of the host immune response to tumor, but the role of TILs in melanoma mortality is controversial. The aim of this study was to investigate independent prognostic factors for melanoma mortality. We carried out a 10-year cohort study on 4133 melanoma patients from the same geographic area (Lazio) with primary cutaneous melanoma diagnosed between January 1998 and December 2008. The probability of survival was estimated using Kaplan-Meier methods and prognostic factors were evaluated by multivariate analysis (Cox proportional hazards model). The 10-year survival rate for melanoma decreased with increasing Breslow thickness (P for trend < 0.0001) and with age (P for trend < 0.0001) whereas survival increased with increasing levels of TILs (P for trend = 0.0001). The 10-year survival rate for melanoma divided into TILs intensity as scanty, moderate, and marked was 88.0, 92.2, and 97.0%, respectively. In the multivariate Cox model, the presence of high levels of TILs in primary invasive melanomas was associated with a lower risk of melanoma death (hazard ratio 0.32; 95% confidence interval 0.13-0.82) after controlling for sex, age, Breslow thickness, histological type, mitotic rate, and ulceration. After including lymph node status in the multivariate analysis, the protective effect of marked TILs on melanoma mortality remained (hazard ratio 0.37; 95% confidence interval 0.15-0.94). The results of this study suggest that the immune microenvironment affects melanoma survival. Melanoma Res 25:306-311
Introduction
Although melanoma accounts for only a small percentage of skin cancer, it is far more aggressive than other skin cancers and causes most skin cancer deaths. Melanoma is 20 times more common in white than in African individuals. Overall, the lifetime risk of developing melanoma is about 2% (one in 50) for white, 0.5% (one in 200) for Hispanic, and 0.1% (one in 1000) for black people [1] . In Europe, it has been estimated that out of 100.3 thousand new cutaneous melanoma (CM) cases occurring, 47.2 thousand occur in men, and 53.1 thousand occur in women. CMs caused 22.2 thousand deaths from cancer in Europe in 2012 [2] .
Histopathologic information is crucial for appropriate management and for predicting the prognosis in patients diagnosed with primary CM. According to the American Joint Committee on Cancer Melanoma Staging Database and Classification (AJCC 2009), Breslow thickness is the most important prognostic factor for localized CM, followed by ulceration and mitotic rate. The probability of 10-year survival for melanoma patients with lesion thickness 1.00 mm or lower is 92%, whereas it is 80% for patients with melanoma from 1.01 to 2.00 mm thickness, 63% for patients with melanomas from 2.01 to 4.00 mm thickness, and 50% for patients with melanoma with more than 4.00 mm thickness. Survival rates of patients with an ulcerated melanoma are lower than those of patients with a nonulcerated melanoma of the same Breslow thickness category, but survival is similar to that of patients with a nonulcerated melanoma of the next highest Breslow thickness category. As ulceration is highly associated with the mitotic rate in patients with lesion thickness 1.00 mm or lower, and the 10-year survival rate is very similar irrespective of the mitotic rate, the presence of mitotic rate (≥1/mm 2 ) or the presence of ulceration is the criterion for defining T1b melanoma in the seventh edition melanoma staging system [3] .
However, there are other parameters of primary CM that have also, but not consistently, been reported to be associated with prognosis such as tumor regression, growth phase, and anatomic site [4] [5] [6] . Another putative and controversial parameter is the presence of tumorinfiltrating lymphocytes (TILs) [7] [8] [9] . There is some All supplementary data are available directly from the corresponding author. evidence of the association between TIL response and sentinel lymph node metastasis [7, 9, 10] . However, epidemiological evidence supporting an association between TIL and melanoma mortality is limited and controversial [7, 10, 11] . The present study aimed to investigate whether TIL was an independent prognostic factor for 10-year melanoma-specific mortality in 3306 invasive primary CM (≥0.1 mm) after controlling for all known prognostic factors including lymph node status.
Study design
A 10-year cohort study was conducted on 4133 melanoma patients.
Patients and methods
All data presented were merged from the Melanoma Registry of the Istituto Dermopatico dell'Immacolata (IDI-IRCCS). From January 1998 to December 2008, patients with newly diagnosed CM were registered at IDI. A computer-aided search identified 4133 patients resident in the Lazio region with a single primary CM.
The histological type, tumor thickness, ulceration, regression, and cellular types were recorded and followed the guidelines described elsewhere [12, 13] . The International Classification of Diseases (ICD-9) was used to classify the anatomic site and cause of death. Patients with a thickness of 1 mm and more underwent wide excision, lymphatic mapping, and sentinel lymph node biopsy (SLNB) [14] .
To be considered as TILs, lymphocytes must infiltrate and disrupt tumor nests and/or must be in direct contact with tumor cells. Three hundred randomly selected pathology reports out of 908 were reviewed by an external pathologist. The intensity of TILs was classified according to percentages. TILs was classified for intensity as follows: grade 1 (scanty) if few lymphocytes infiltrated the tumor focally or multifocally throughout or at the base of the dermal component (30% or less of the component was infiltrated by lymphocytes); grade 2 (moderate) moderate amounts of lymphocytes infiltrated the tumor focally or multifocally, but not along the entire base of dermal component (31 to 64% of the component was infiltrated by lymphocytes); and grade 3 (marked) if a continuous band of lymphocytes was present at the base or throughout the dermal melanoma component (65% or more of the component was infiltrated by lymphocytes).
Vital status
Files from the Registry Office of the Department of Epidemiology of the Lazio Region were examined to obtain information on vital status and cause-specific mortality. We calculated the length of follow-up for each patient as the number of days from the diagnosis of primary melanoma to the date of death or to 31 December 2009, whichever came first. Patients who were alive or had died from other causes were considered censored.
Statistical methods
The Kaplan-Meier method was used to calculate crude survival by baseline characteristics and by levels of tumor thickness, Clark level, histological type, and site of tumor, presence of ulceration, pre-existing nevus, regression, mitotic rate, and TILs. To test whether the effect of TILs on melanoma survival would increase systematically with the level of TILs, we tested for trend (log-rank test trend). Cox proportional hazards models were used to investigate the association between mortality and clinical and histological features. We assessed the potential for violation of the proportional hazards assumption by comparing the survival curves for each level of a variable. Scaled Schoenfeld and Martingale residuals analyses were also used. The likelihood ratio test was used to decide whether to retain each covariate in the model. Only those variables that made statistically significant contributions toward the model were included. We tested for potential effect modification by age, sex, Breslow, and anatomic site for intensity of TILs. Data were analyzed using STATA software (Stata 11.0; StataCorp LP, College Station, Texas, USA).
Results
Of the 4133 patients with CM, 3306 cases (80.0%) were invasive. The mean age of the patients was 55.0 years (SD = 16.9 years) (48.1% men and 51.9% women). In the study population, there were 502 deaths, 209 of which were because of melanoma. The median follow-up time was 5.30 years for a total of 23 367 person-years of followup.
The TIL grade among the invasive melanoma cases was grade 1 (scanty) (46.8%), followed by grade 3 (marked) and 2 (moderate) (27.3 and 25.9%, respectively). There was a difference, although not statistically significant, in the distribution of patient age between the TIL groups, with patients with grades 2 and 3 tumors being younger [median age 56 and 57 years, respectively, compared with 60 years for grade 1 (scanty)]. The presence of regression was associated positively with TIL grade (P = 0.02), whereas Breslow thickness, ulceration, and mitotic rate were all associated inversely with TIL grade (P < 0.0001). Patients with low levels of TILs were more likely to have positive SLNB (25.6%) compared with patients with high TILs (7.8%) (P = 0.01). Table 1 shows the 10-year crude survival by clinical and histological characteristics, the crude hazard ratio (HR), and 95% confidence intervals (CIs) estimated using the Cox proportional hazards models. The overall 10-year survival for melanoma was 92.5%, but when divided into four primary tumor thickness categories of 0.01-1.00, 1.01-2.00, 2.01-4.00, and over 4.00 mm, 10-year figures were 98.2, 84.2, 67.0, and 57.4%. Survival decreased with increasing Breslow thickness (P for trend < 0.0001) and with age (P for trend < 0.0001), whereas survival increased with increasing levels of TILs (P for trend = 0.0001). Ten-year survival rates for melanoma divided into TILs intensity as scanty, moderate, and marked were 88.0, 92.2, and 97.0 ( Fig. 1 ).
Initially, a univariate Cox regression analysis was carried out to evaluate the association between individual potential predictor factors and melanoma mortality. Male patients had a 60% increased risk of melanoma death compared with female patients (HR: 1.60; 95% CI: 1.21-2.10). The most powerful predictor of death after thickness was mitotic rate (HR: 7.65; 95% CI 5.51-10.6), followed by types of melanoma (nodular form vs. superficial spreading HR: 7.00; 95% CI 5.26-9.32) and ulceration (HR: 5.61; 95% CI 4.09-7.70). A protective effect for melanoma mortality was found for the presence of TILs (moderate vs. scanty, HR 0.47; 95% CI 0.24-0.92) and (marked vs. scanty, HR 0.21; 95% CI 0.08-0.52) and the presence of regression (HR 0.38; 95% CI 0.20-0.71) (Table 1) .
Multivariate Cox regression models were developed to estimate melanoma mortality HRs and 95% CIs in 3306 invasive melanoma patients. A basic model that included the dependent variables of interest, sex, age, Breslow thickness, mitotic rate, and the presence of ulceration was constructed first (model 0). All variables included in the multivariate basic model were independent factors for CM mortality, except for sex, which did not reach statistical significance (men vs. women, HR 1.20; 95% CI 0.90-1.59). Then, histological type was added to the Table 2 ). Clark showed that TILs was an independent prognostic factor significant in the vertical and not in the radial growth phase of melanomas. Thus, we carried out a further analysis excluding cases with radial growth phase. When patients with the radial growth phase were excluded, the results were very similar (marked TILs vs. scanty, HR 0.32; 95% CI 0.12-0.81) [15] .
Other candidate covariates were selected and added, one at a time, to the final model as follows: regression, preexisting nevus, anatomic site, Clark level, and lymph node status. None of the latter variables altered the results in terms of the protective effect of marked TILs on melanoma mortality, including lymph node status (HR 0.37; 95% CI 0.15-0.94) ( Table 3) .
Disease-specific mortality is the most widely accepted end-point; however, misclassification in the cause of death may occur in disease-specific mortality. Therefore, it may be useful to interpret in conjunction with all-cause mortality (supplementary Table 1 ). Therefore, the model 2 was rerun using all-cause mortality and the effect of TILs on mortality remained (marked TILs vs. scanty, HR 0.61; 95% CI 0.40-0.94, P = 0.03).
Discussion
Increasing evidence suggests that adaptive immunity plays an important role in controlling cancer initiation and progression [16] [17] [18] . At the core of these findings lies the fact that melanoma patients can produce T lymphocytes that recognize tumor-specific antigens. TILs are considered to reflect a specific host response that results from recognition of tumor-associated antigens either on antigen-presenting cells or on the surface of the tumor cells by T lymphocytes [19] . The findings of the present study show that a marked TILs response in primary invasive CM is a protective and independent prognostic factor for 10-year melanoma-specific mortality after controlling for all known prognostic factor for melanoma mortality, including lymph nodes status. In our study, patients with marked TILs had less than half the risk of melanoma-specific mortality in comparison with patients with scanty TILs. Percentage melanoma survival by tumor-infiltrating lymphocytes. Our study confirms the observations made by Moore and Foote [20] more than 50 years ago on breast cancer and later on melanoma [21] . Moore and Foote [20] observed that breast cancer patients whose tumors had high numbers of TILs had a good prognosis, whereas patients with few or no TILs had a poor prognosis. Subsequently, Day et al. [21] reported that melanoma patients (N = 101) with moderate to marked infiltrate lymphocytes within the lesion had a better prognosis in terms of 5-year disease-free survival than those with sparse or absent TILs. In 1989, Clark et al. [15] defined and classified the lymphocyte infiltrate into absent, nonbrisk, and brisk categories according to their distribution and intensity and showed that the presence of TILs among patients with the vertical growth-phase melanomas was associated with a high probability of remaining alive at 8 years. Successively, the prognostic importance of TILs in terms of overall survival was confirmed by some studies [7, 11, 22] , but not all [8] [9] [10] . The existing controversy on TILs as a prognostic factor for melanoma-specific mortality may be explained by different TILs classification, followup durations in different studies, by small sample sizes, and differences in the study population investigated (e.g. inclusion criteria for Breslow thickness, growth phase). In the study of Barnill et al. [8] , a total of 548 patients were included and TILs were classified as absent and present. No protective effect was found for the presence of TILs in terms of the 5-year melanoma-specific mortality. In the study of Burton and colleagues, a total of 515 patients with CM of 1.00 mm or more of Breslow who underwent SLNB were followed up for 5 years. TILs was not an independent predictor for melanoma mortality in the latter study [10] . A study carried out by Rao and colleagues in 293 patients with thick melanomas (pT4) showed that the presence of TILs was associated with improved 5-year survival rates among patients not treated with interferon α2b. However, no benefits was found for the presence of TILs among patients treated with interferon α2b [22] . Recent studies with larger sample sizes showed that TILs are an important prognostic factor for 5-year melanoma-specific mortality [7, 23] . Azimi and colleagues carried out a study with 18 865 patients with primary melanoma with 0.75 mm of Breslow or more and showed that TIL grade (4 vs. 0) was an independent predictor of 5-year melanoma-specific mortality. Our data are similar to the findings of Clemente and colleagues, who showed that high TIL response (brisk vs. absent) decreases the risk of 10-year melanoma-specific mortality by almost half after adjustment in the multivariate model for sex and Breslow thickness (risk ratio: 0.56, P =0.04). However, the study was limited to 285 melanoma patients who had vertical growth phase and no regional metastasis [11] . In our study, we included all invasive melanomas from 0.1 mm and we controlled in the multivariate model not only for sex and Breslow but also for age, ulceration, mitotic rate, histological type, and lymph node status. The limitations of our study include the lack of data on functionally distinct TIL subsets that may improve the understanding of the prognostic significance of TILs. However, the aim of our study was to evaluate the prognostic significance of total TILs on melanomaspecific mortality, controlling for all known prognostic factors. A central pathology review of all slides could also be a limitation of the study. However, 300 randomly selected pathology reports out of 908 were reviewed by an external pathologist.
Finally, our data show that TIL intensity is an important prognostic factor for melanoma survival, independent of the tumor characteristics currently used for AJCC tumor stage. In view of our findings and the renewed interest in studying TILs, mostly in the context of their value as a biomarker in cancer [23] , we suggest that TILs may be part of the minimum dataset of the pathology reporting of CM. International multi-center studies are warranted to determine whether TILs may be included in future AJCC melanoma staging revisions.
